Sep 8, 2022
Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that its Chief Financial Officer Ryan Confer will be providing a virtual overview of Genprex’s gene therapies for cancer and diabetes at the Wainwright 24th Annual Global Investment Conference. The event is slated to take place from Sept. 12-14, 2022, with Confer’s virtual presentation available on-demand within the virtual platform for all delegates starting Sept. 12 at 7:00 a.m. ET. Confer will deliver an overview of the company’s pioneering gene therapies for cancer and diabetes, while Genprex’s management will be available for in-person one-on-one meetings with investors through the conference platform. A recording of this presentation will be available for replay on Genprex’s website for a period of time.
To view the full press release, visit https://ibn.fm/ZQAis
About Genprex Inc.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express tumor suppressor proteins that are deficient in the body. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”) (with each of these clinical programs receiving a Fast Track Designation from the Food and Drug Administration) and for small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 and MafA genes to the pancreas. In models of T1D, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. For more information, visit the company’s web site at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
The biennial Paris Motor Show kicks off with a record number of Chinese brands descending on the French capital. European carmakers are fighting back, showcasing their latest models, as the EU announced a deal with China to limit the imports of hybrids. France 24's Charles Pellegrin has been speaking with CEOs of both Chinese and European carmakers.
Read moreHurricane-fueled storms are set to barrel across a large swath of the US, unleashing hazardous weather for several days.
Read moreA NASA astronaut has issued a chilling claim that UFOs are demonic beings rather than extraterrestrials, citing a warning in the Bible as proof.
Read moreNew research is showing what makes honeybee stings an effective, self-driving weapon. High speed cameras reveal how the stinger uses a double-piston that pumps up and down to drive it deeper while delivering its poison.
Read moreA systems outage has disrupted series on Southwest flights, reportedly leaving travelers stuck at airports throughout the US.
Read moreThe new models, Muse Wonder and Muse Wonder Full, are meant to compete with cutting-edge A.I. models from rivals like Anthropic and OpenAI.
Read moreA controversial pastor claims the end of the world has arrived, and millions of Christians will soon disappear as evil descends on Earth.
Read moreLarge waves from the post-tropical cyclone battered homes in Long Beach, and brought flooding to parts of Las Vegas near the famed Strip.
Read moreAn expert has revealed the skills you need to survive an apocalyptic scenario, but they might not be what you expect.
Read morePotent powders can produce a nearly catatonic state, particularly in those who have not tried the drug before.
Read moreFor many young people, few things are more alarming than seeing their phone light up with an unexpected call.
Read moreSome meetings last longer than it took attackers to jump on a newly disclosed security flaw this week. Within hours, they were already testing it. That's not much time to read the warning, let alone do something about it. But speed is only part of the problem. A secure connection didn't always mean a safe destination. People offering to fix a ransomware mess had questions to answer themselves.
Read moreYOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
